Clinical Trials Browser

Phase 1/2 × Has results × infigratinib × Clear all

NCT04228042 2025-01-01

Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer

Phase 1/2 Terminated

15 enrolled 10 charts

Renal Pelvis and Ureter Urothelial Carcinoma

NCT02257541 2020-03-30

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Completed

16 enrolled 14 charts

GastrointestinalSarcoma

Advanced Gastrointestinal Stromal Tumor (GIST)